PNC Financial Services Group’s La Jolla Pharmaceutical Company LJPC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-7,000
| Closed | -$22K | – | 4748 |
|
|
2022
Q2 | $22K | Hold |
7,000
| – | – | ﹤0.01% | 3465 |
|
|
2022
Q1 | $30K | Hold |
7,000
| – | – | ﹤0.01% | 3387 |
|
|
2021
Q4 | $33K | Hold |
7,000
| – | – | ﹤0.01% | 3337 |
|
|
2021
Q3 | $28K | Hold |
7,000
| – | – | ﹤0.01% | 3378 |
|
|
2021
Q2 | $30K | Hold |
7,000
| – | – | ﹤0.01% | 3319 |
|
|
2021
Q1 | $30K | Hold |
7,000
| – | – | ﹤0.01% | 3248 |
|
|
2020
Q4 | $27K | Hold |
7,000
| – | – | ﹤0.01% | 3217 |
|
|
2020
Q3 | $28K | Hold |
7,000
| – | – | ﹤0.01% | 3068 |
|
|
2020
Q2 | $30K | Hold |
7,000
| – | – | ﹤0.01% | 3028 |
|
|
2020
Q1 | $29K | Hold |
7,000
| – | – | ﹤0.01% | 2942 |
|
|
2019
Q4 | $28K | Buy |
7,000
+2,981
| +74% | +$17.6K | ﹤0.01% | 3191 |
|
|
2019
Q3 | $35K | Hold |
4,019
| – | – | ﹤0.01% | 3113 |
|
|
2019
Q2 | $37K | Buy |
+4,019
| New | +$30.3K | ﹤0.01% | 3099 |
|
|
2017
Q2 | – | Sell |
-2,860
| Closed | -$86K | – | 4369 |
|
|
2017
Q1 | $86K | Buy |
+2,860
| New | +$73K | ﹤0.01% | 2591 |
|
|
2016
Q3 | – | Sell |
-31
| Closed | – | – | 4728 |
|
|
2016
Q2 | $0 | Sell |
31
-1
| -3% | -$18 | ﹤0.01% | 4743 |
|
|
2016
Q1 | $1K | Buy |
32
+1
| +3% | +$18 | ﹤0.01% | 4488 |
|
|
2015
Q4 | $1K | Buy |
+31
| New | +$845 | ﹤0.01% | 4444 |
|
PNC Financial Services Group's LJPC Position: Q3 2022 in Review
PNC Financial Services Group sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2022, closing a stake of 7,000 shares — an estimated $22K sold.
PNC Financial Services Group first reported a position in LJPC in Q4 2015 and held it in 17 quarters. The position peaked at $86K in Q1 2017. 0 funds tracked by Wall St. Rank hold LJPC as of Q3 2022.
- PNC Financial Services Group reported no remaining La Jolla Pharmaceutical Company position as of Q3 2022 after selling out during the quarter.
- PNC Financial Services Group sold 7,000 La Jolla Pharmaceutical Company shares in Q3 2022, an estimated $22K.
- PNC Financial Services Group first reported a position in La Jolla Pharmaceutical Company in Q4 2015 and held it in 17 quarters.
- PNC Financial Services Group's La Jolla Pharmaceutical Company position peaked at $86K in Q1 2017.
- 0 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2022.
Based on PNC Financial Services Group's 13F filing for Q3 2022, filed 10 Nov 2022.